Obstructive sleep apnea severity, Alzheimer's disease plasma markers, and CSF brain amyloidosis and tau pathology
Alzheimer's & Dementia · 2026
DOI: 10.1002/alz.71270 ↗Kurz gefasst
Fachartikel in der Zeitschrift Alzheimer's & Dementia, 2026. Verfasst von Omonigho Michael Bubu und 25 weiteren Autor:innen. Beteiligte Einrichtung: Healthy Brain Aging and Sleep Center, Department of Psychiatry, New York University Grossman School of Medicine, New York, New York, USA. Hauptthemen laut MEDLINE: Sleep Apnea, Obstructive, Alzheimer Disease, Amyloidosis, Patient Acuity. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 70 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIH HHS, NIA NIH HHS, Alzheimer's Association/Michael J. Fox Foundation/CurePSP.
Themen: Demenz
Abstract (Originalsprache)
INTRODUCTION We examined obstructive sleep apnea (OSA) severity's association with Alzheimer's disease (AD) plasma biomarkers, independent or synergistic with cerebrospinal fluid (CSF) amyloid, and as a proof of concept, whether plasma amyloid beta (Aβ)42/Aβ40 with OSA severity improves detection of amyloidosis and tau pathology. METHODS In 120 cognitively normal older adults (70 with CSF data) from New York University sleep and aging studies (2013–2021), OSA severity was measured using apnea/hypopnea index with 4% desaturation; plasma Aβ40, Aβ42, tau, and neurofilament light chain (NfL) via single molecule array; CSF amyloid and tau via enzyme‐linked immunosorbent assay. Associations evaluated adjusted correlations and generalized models; receiver operating characteristic analyses evaluated diagnostic accuracy. RESULTS OSA severity correlated with plasma Aβ40 ( r = 0.21), Aβ42 ( r = 0.26), and Aβ42/Aβ40 ( r = 0.20). Plasma tau and NfL associations depended on CSF–Aβ42. OSA severity with Aβ42/Aβ40 improved CSF amyloidosis (area under the curve [AUC] = 0.78) and tau pathology (AUC = 0.71) detection. DISCUSSION OSA severity relates to elevated plasma Aβ and, with CSF amyloid, to tau/NfL. Combined plasma and OSA measures aid non‐invasive AD associations’ detection.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Healthy Brain Aging and Sleep Center, Department of Psychiatry, New York University Grossman School of Medicine, New York, New York, USA.
- Institute of Excellence in Health Equity, Department of Population Health, New York University Grossman School of Medicine, New York, New York, USA.
- Alzheimer's Disease Research Center and Center for Cognitive Neurology, Department of Neurology, New York University Grossman School of Medicine, New York, New York, USA.
- Neuroscience Institute, New York University Grossman School of Medicine, New York, New York, USA.
- Division of Pulmonary, Critical Care and Sleep Medicine at the Icahn School of Medicine at Mount Sinai, New York, New York, USA.
- Department of Epidemiology and Infection Control, State University of New York Downstate Medical Center, Brooklyn, New York, USA.
ORCID-Profile: Omonigho Michael Bubu
Förderung
- NIH HHS
- NIA NIH HHS
- Alzheimer's Association/Michael J. Fox Foundation/CurePSP
- BrightFocus Foundation
- Alzheimer's Association
- National Institutes of Health
Zitieren
APA
Bubu, O. M., Mullins, A. E., Shah, S., Gills, J. L., Kam, K., Parekh, A., Umasabor-Bubu, O. Q., Turner, A. D., Bernard, M., Briggs, A., Ramos-Cejudo, J., Valkanova, E., Mbah, A. K., Pahari, P., Debure, L., Ghuman, M., Boutajangout, A., Williams, N. J., Hwang, J., …, & Osorio, R. S. (2026). Obstructive sleep apnea severity, Alzheimer's disease plasma markers, and CSF brain amyloidosis and tau pathology. Alzheimer's & Dementia. https://doi.org/10.1002/alz.71270
Vancouver
Bubu OM, Mullins AE, Shah S, Gills JL, Kam K, Parekh A, et al. Obstructive sleep apnea severity, Alzheimer's disease plasma markers, and CSF brain amyloidosis and tau pathology. Alzheimer's & Dementia. 2026. doi:10.1002/alz.71270
BibTeX
@article{Bubu2026,
author = {Bubu, Omonigho Michael and Mullins, Anna E and Shah, Shreshtha and Gills, Joshua L and Kam, Korey and Parekh, Ankit and Umasabor-Bubu, Ogie Q and Turner, Arlener D and Bernard, Mark and Briggs, Anthony and Ramos-Cejudo, Jaime and Valkanova, Elena and Mbah, Alfred K and Pahari, Purbanka and Debure, Ludovic and Ghuman, Mobeena and Boutajangout, Allal and Williams, Natasha J and Hwang, Jeongyeon and Williams, Masrai K and Rapoport, David M and Ayappa, Indu and de Léon, Mony and Jean-Louis, Girardin and Varga, Andrew W and Osorio, Ricardo S},
title = {Obstructive sleep apnea severity, Alzheimer's disease plasma markers, and CSF brain amyloidosis and tau pathology},
journal = {Alzheimer's & Dementia},
year = {2026},
doi = {10.1002/alz.71270}
}
EUVIMED